Início
Explorar
nav.journalClub
Tendências
Mais
synapse
⌘+K
Idioma
Português
Português
March 3, 2026
What is the Consensus Value of Patients’ Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease
FJ
Freed Johnson
AS
Amit K. Srivastava
JY
Jui-Chen Yang
Key Points
Patients express varying levels of treatment-risk tolerance for inflammatory bowel disease, emphasizing distinct preferences.
The study highlights that understanding these preferences is crucial for tailored treatment strategies, enhancing patient satisfaction.
Observational analysis collecting stated-preference data from patients was conducted, emphasizing the importance of personalized care.
Findings may enable healthcare providers to offer better treatment options aligned with patient values, improving outcomes.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Johnson et al. (Sun,) studied this question.
synapsesocial.com/papers/69a7603fc6e9836116a2ccb1
https://doi.org/https://doi.org/10.1016/j.jval.2026.01.012
What is the Consensus Value of Patients’ Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease | Synapse